NCT04254471 2020-02-05
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
Haihe Biopharma Co., Ltd.
Phase 2/3 Unknown
Clinical Trials
3 trialsNCT04192682 2020-01-06
Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University
Phase 2/3 Unknown
NCT00168896 2006-02-14
A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Charite University, Berlin, Germany
Phase 2/3 Unknown